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Objectives
The NHANES II Mortality Study is a
prospective study of adult participants
examined in the second National Health
and Nutrition Examination Survey
(NHANES II) conducted between 1976
and 1980. It was designed to investigate
the association between factors
measured at baseline and mortality. The
methods used in the study are described
and assessed in this report.
Methods
The vital status of NHANES II
participants who were 30–75 years of
age at their examination was ascertained
after 12–16 years. Vital status was
assessed by searching the National
Death Index and the Social Security
Administration Death Master File for
deaths occurring in the United States.
Causes of death were obtained from the
National Center for Health Statistics
Multiple Cause of Death file or death
certificates. To assess how well mortality
was ascertained, the survival of the
cohort after 5 and 10 years was
compared to that of the U.S. population
during the same period.
Results
As of December 31, 1992,
23.2 percent of the 9,250 cohort
members were found to be deceased.
The remaining 76.8 percent that were not
found to be deceased may be assumed
to be alive for analytic purposes.
Cumulative survival probabilities for the
cohort were generally higher than
probabilities calculated from U.S. life
table data. Although some differences
were expected, these data suggest that
after 10 years of follow-up using passive
methods, mortality may have been under
ascertained for the cohort. Discrepancies
between the survival patterns for
NHANES II cohort and U.S. vital statistics
were larger for black than for white
participants, indicating that ascertainment
of mortality was poorer among black
participants. Researchers using the
NHANES II Mortality Study, 1992 data
should be aware of these study limitations.
Keywords: Epidemiologic methods c
data collection c health surveys c
cohort studies c longitudinal study c
follow-up studies
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PreventionBackground
The NHANES II Mortality Study isa prospective cohort study, whichpassively followed a subset
of participants in the Second National
Health and Nutrition Examination Survey
(NHANES II). NHANES II, conducted
between 1976–80, collected data from a
national probability sample of the U.S.
civilian, noninstitutionalized population
6 months–74 years of age (1). The
survey included a standardized physical
examination, laboratory tests, and
questionnaires that covered various
health-related topics. NHANES II
provided a wealth of information on the
prevalence of health conditions and risk
factors. Nevertheless, the cross-sectional
nature of the original survey limits its
usefulness for studying the effects of
clinical, environmental, and behavioral
factors on the development of specific
health conditions.
The NHANES II Mortality Study
was designed to investigate the
association between factors measured at
baseline and overall mortality or death
from specific causes. NHANES II
obtained information gathered from
physical examinations, laboratory tests,
and interviews, whereas the NHANES II
Mortality Study involved searching
national data bases containing
information about mortality and causesof death. Mortality data from the
NHANES II Mortality Study can be
linked with the earlier baseline
NHANES II data to examine the
relationships between various factors
and specific causes of death.
Note that the design of the
NHANES II Mortality Study differs
substantially from that of the
NHANES I Epidemiologic Followup
Study (NHEFS), a longitudinal
follow-up of an earlier NHANES
cohort (2–5). NHEFS was an active
follow-up study in which participants
were recontacted and medical records
and death certificates were obtained. In
contrast, the NHANES II Mortality
Study is entirely passive, that is,
participants were not recontacted.
Instead, mortality status was ascertained
solely by computerized matching to
national data bases and evaluation of the
resulting matches. Furthermore, no
recontact is planned in the future.
Instead, matching to the National Death
Index (NDI) and other national data
bases will continue periodically. Future
waves will be released for public use as
they become available. One important
consequence of the NHANES II Mortality
Study design is that persons not found to
be deceased are assumed alive for analytic
purposes. As a result the potential for
misclassification of vital status exists.
Researchers using data from the
NHANES II Mortality Study should be
aware of this study limitation.Page 1
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Health and Nutrition
Examination Survey
(1976–80)
An understanding of the
NHANES II study design and
procedures is needed to use the
NHANES II Mortality Study, 1992
data effectively. A brief overview of
the baseline study design and methods
is provided as follows and reported in
more detail elsewhere (1).
NHANES II was designed to collect
extensive demographic, medical history,
nutritional, clinical, and laboratory data
on a probability sample of the civilian,
noninstitutionalized population between
the ages of 6 months and 74 years (1).
The survey, conducted between
1976–80, had a complex sample design
consisting of a multistage, stratified,
probability-based cluster sample of
households throughout the United
States (1). The primary sampling units,
which consisted of a county or group of
contiguous counties, were stratified
according to demographic characteristics
and geographic region and grouped into
64 superstrata. One primary sampling
unit was selected from each
superstratum using a control selection
procedure to produce a balanced sample
with respect to variables such as region,
State group, race-ethnicity, and poverty
level (1). Within each primary sampling
unit, census enumeration districts,
stratified by poverty level, were selected
with probability proportional to their
size. Households within selected
enumeration districts were clustered into
segments. One segment was
systematically selected within each
enumeration district. Approximately one
person was sampled from each
household with oversampling of persons
6 months–5 years of age and 60–74
years of age.
A standardized set of questions and
examination procedures was
administered by centrally trained staff
and blood was drawn for various
laboratory tests (1). At the initial visit to
the household, interviewers introduced
the survey, administered questionnaires,
and made appointments for the
examination. Interviewers also obtainedconsent to retrieve additional
information from records including
those from physicians, hospitals,
schools, and State registry offices (1).
Interviews and examinations were
conducted from Tuesdays through
Saturdays in mobile examination
centers (MEC’s). Each MEC consisted
of three trailers connected by enclosed
passageways and was divided into
separate rooms for examination
components, including a laboratory for
processing blood and other biological
samples. The examination and
interview lasted, on average, 2–3
hours. Quality control procedures
included centralized training and
periodic retraining of field staff,
routine calibration of instruments,
replicate measures for a subset of
participants, and duplicate specimen
processing for biochemical
measures (1).
NHANES II Mortality
Study, 1992 Study
Design
The NHANES II Mortality Studycohort consists of adults whowere 30–75 years of age at
the time of their NHANES II
examination. This cohort is a subset of
the approximately 28,000 persons
selected to participate in NHANES II.
Some participants were interviewed but
not examined and only those examined
were followed for mortality status. The
baseline included persons between the
ages of 6 months and 74 years but only
adults were included in the follow-up
cohort. Age at examination was used to
identify participants 30 years of age and
over for selection into the NHANES II
Mortality Study, 1992 cohort. Because
several weeks could have elapsed
between the interview and examination,
some participants who were 74 years of
age during their interview turned 75
years of age between their interview and
examination. Therefore, the upper age
limit for the NHANES II Mortality
Study, 1992 cohort is 75 years. At
baseline, 12,102 adults 30–74 years ofage agreed to be interviewed and 9,252
(76 percent) completed a physical
examination.
During this first wave of the
study, mortality status was ascertained
for the years 1976–92. Two
participants were unable to be
followed because of incomplete
personal identifying data and are
considered lost to follow-up. The
remaining 9,250 cohort members were
traced in the NHANES II Mortality
Study, 1992 by searching national data
bases containing mortality and cause
of death information. Length of
follow-up ranges from 12 through 16
years. Approximately 23 percent
(n = 2,145) of the NHANES II
Mortality Study, 1992 cohort were
found to be deceased as of December
31, 1992 (figure 1).
Mortality Ascertainment
Mortality status was ascertained by
searching two computerized data bases
containing information on deaths
occurring in the United States. The NDI,
compiled by the National Center for
Health Statistics (NCHS), contains a
standard set of identifying data for each
decedent provided by State vital
statistics offices (6,7). Beginning with
deaths occurring in 1979, the NDI
contains deaths for all 50 States, the
District of Columbia, Puerto Rico, and
the Virgin Islands (6). The Social
Security Administration’s (SSA) Death
Master File (DMF) contains information
on all U.S. decedents whose
beneficiaries received death benefits
from the SSA (8). The DMF pools data
from a variety of SSA files, including
the SSA Master Beneficiary Record that
contains a record for each person
entitled to receive retirement or
survivor’s benefits and disability
insurance.
The results of each search were
evaluated separately and later combined
using the following process (also,
outlined in figure 2) to create the
NHANES II Mortality Study, 1992
public-release file.
Figure 1. Tracing status of participants in the NHANES II Mortality Study, 1992 cohort
Series 1, No. 38 [ Page 3National Death Index Search
The NDI was searched for deaths
occurring between 1979–92. At the time
the NHANES II Mortality Study, 1992
data were collected, 1992 was the latest
year for which cause of death data were
available. Social Security numbers were
not collected during NHANES II;
therefore, potential matches with the
NDI were initially identified using
name, date of birth, and sex, according
to the standard NDI matching
process (6). These NDI matching criteria
are liberal enough to ensure that true
matches will not be missed, but also
they generally yield many false matches,
especially for participants with common
names.
In an attempt to eliminate false
positive matches, all matches returned
by the NDI were manually reviewed
using the previously mentioned
information and, additionally, observed
race, State of birth, State of residence,
and marital status. Each potential NDI
match was tentatively classified by
NHANES II Mortality Study, 1992 staff
as ‘‘true,’’ ‘‘possible,’’ or ‘‘false.’’ The
only exceptions to this manual review
process were those matches that
matched all fields exactly (i.e., name,
date of birth, sex, observed race, State
of birth, State of residence, and marital
status); these matches were classified as
true without further review (54 percent
of 1,973 true matches). For all other
NDI matches, a ‘‘true’’ classification
was assigned if enough evidence existed
to assume that the death pertained to the
NHANES II participant. A ‘‘possible’’
was assigned if NHANES II Mortality
Study, 1992 staff were uncertain whetherthe death pertained to the NHANES II
participant based on the available
evidence from the NDI. This code was
used to identify cases for whom the
death certificate identified by the
potential match should be ordered to
allow for further evaluation. A ‘‘false’’
was assigned if the available evidence
from the NDI suggested that the death
did not pertain to the NHANES II
participant. Overall, NHANES II
Mortality Study, 1992 staff erred on the
side of being conservative and assigned
a possible if they were uncertain in
either direction.
Social Security Administration
Death Master File Search
Because the NDI does not include
deaths occurring before 1979, the SSA
DMF was searched for deaths occurring
in 1976–78. Additionally, the DMF was
also searched from 1979 through March
31, 1988, to confirm the NDI match
results for this period. Data extracted
from the DMF after March 1988 were
not available at the time this study was
conducted.
As with the NDI, the initial criteria
to identify potential matches to the
DMF were based on name and date of
birth and were liberal enough to ensure
that ‘‘true’’ matches would not be
missed. The quality of potential matches
was further evaluated using a numerical
scoring algorithm based on first and last
name, date of birth, and State of
residence. Matches with scores high
enough to indicate at least partial
matching on name and date of birth
were then manually examined in anattempt to eliminate ‘‘false’’ matches.
Besides name and date of birth, these
evaluations used the last known State of
residence compared with the Zip code
where the lump sum payment was sent.
Each DMF match was tentatively
classified by NHANES II Mortality
Study, 1992 staff as true, possible, or
false. A ‘‘true’’ classification was
assigned if enough evidence existed to
assume that the death pertained to the
NHANES II participant. A ‘‘possible’’
was assigned if NHANES II Mortality
Study, 1992 staff were uncertain whether
the death pertained to the NHANES II
participant based on the available
evidence from DMF. The ‘‘possible’’
code was used to identify cases for
whom the death certificate identified by
the potential match should be ordered to
allow for further evaluation. A ‘‘false’’
was assigned if the available evidence
from DMF suggested that the death did
not pertain to the NHANES II
participant. Overall, NHANES II
Mortality Study, 1992 staff erred on the
side of being conservative and assigned
a ‘‘possible’’ if they were uncertain in
either direction.
Combination of the National
Death Index and Death Master
File Searches for 1979–88
When the NDI and DMF results
were combined, differing outcomes
existed for some NHANES II
participants. For example, NCHS staff
may have assigned a ‘‘true’’ match
based on NDI and a ‘‘possible’’ match
based on DMF for the same participant.
In some cases, NDI and DMF could
have been referring to the same death
certificate, but NHANES II Mortality
Study, 1992 staff could not be certain
because DMF did not provide the death
certificate number. The dates of death
were used to identify cases where NDI
and DMF were most likely referring to
the same death certificate.
Because very few cases existed
where the NDI and DMF dates of death
differed, NHANES II Mortality Study,
1992 staff were able to order the death
certificates for both matches from State
vital statistics offices. If the certificates
were received, they were evaluated to
resolve the discrepancy. Data on the
Figure 2. An overview of the process used to assign mortality status to the NHANES II
Mortality Study, 1992 participants
Page 4 [ Series 1, No. 38death certificate, including address,
spouse, State of birth, next of kin, race,
marital status, and usual occupation,
were checked against these data
collected during NHANES II. Based on
this review, NHANES II Mortality
Study, 1992 staff decided which of the
two matches, if any, pertained to the
NHANES II participant.More cases existed where the death
dates from NDI and DMF matched
exactly or were fairly close (e.g., the
year was the same but the month
differed, and it looked like a
transposition error). In such cases, it
was assumed that NDI and DMF were
referring to the same death certificate.
Before ordering death certificates,NHANES II Mortality Study, 1992 staff
assigned an outcome that gave more
weight to the NDI results because more
information was used in the matching
process for NDI (i.e., name, gender, date
of birth, race, State of birth, State of
residence, and marital status) as
compared with DMF (i.e., name,
gender, date of birth, and State of
residence). However, the NDI-based
outcome may have been changed in
these discrepant cases if the
DMF-identified death certificate was
reviewed and it was determined that
the DMF match pertained to the
NHANES II participant.
Death Certificate Ordering and
Review
Because of limited resources for
this study, NHANES II Mortality Study,
1992 staff were unable to order death
certificates from States and evaluate all
of the true and possible matches
identified from the NDI and DMF. The
matches were ranked and as many of
the death certificates as resources
allowed were ordered. Priority was
given to the following:
+ Matches for which NHANES II
Mortality Study, 1992 staff could not
obtain the cause of death from
internal NCHS files.
+ Cases with discrepant matches from
NDI and DMF in which the dates of
death differed.
+ ‘‘True’’ and ‘‘possible’’ matches
identified solely through DMF
(because NCHS had received so
little information from DMF to
determine whether the match
pertained to the NHANES II
participant). NHANES II Mortality
Study, 1992 staff ordered as many
NDI ‘‘true’’ and ‘‘possible’’
matches as resources permitted,
mainly from States that NCHS was
already requesting death
certificates identified by DMF,
because this was the most
cost-effective approach. As a
result, death certificates were
ordered for relatively few NDI
‘‘true’’ and ‘‘possible’’ matches,
because NHANES II Mortality
Study, 1992 staff felt more
Series 1, No. 38 [ Page 5confident given that the NDI
matches used more information in
the matching process.
Death certificates were ordered and
received for approximately 27 percent of
the 2,145 decedents. A small percentage
of the death certificates ordered were
not received for one of the following
reasons:
+ DMF did not provide the State of
death and death certificate number,
and the State vital statistics office
could not find the death certificate
based on name, gender, date of
death, and date of birth.
+ NDI provided the State of death and
death certificate number; but in a
small number of cases, the death
certificate received did not appear to
be the death certificate referenced on
the NDI, possibly because of
typographic errors in the death
certificate number.
NCHS was unable to evaluate all
of the death certificates received
because of staffing limitations. For
deaths occurring during the period
covered by DMF only (1976–78),
death certificates were evaluated for a
sample of the DMF ‘‘true’’ matches to
ensure that criteria for classifying
DMF ‘‘true’’ matches were sensitive.
For the same period, all death
certificates were evaluated for DMF
‘‘possible’’ matches because of the
uncertainty about these matches that
were based on so little information.
Certificates for deaths occurring
between 1979–88 for all ‘‘true’’ and
‘‘possible’’ matches identified solely
through DMF were evaluated in case
the death on the NDI was missed. A
sample of death certificates for all
NDI ‘‘true’’ and ‘‘possible’’ matches
were evaluated to ensure that criteria
for classifying them were sensitive. In
all evaluations data on the death
certificate were checked against these
data collected during NHANES II,
including address, spouse, State of
birth, next of kin, race, marital status,
and usual occupation. About one-third
of the 712 death certificates ordered
and received were reviewed by
NHANES II Mortality Study, 1992
staff.Final Mortality Status on the
Public-Release File
Decedents on the public-release file
consist only of participants with a final
‘‘true’’ match after combining the results
of the NDI and DMF evaluations and
reviewing selected death certificates. For
participants with a final ‘‘possible’’
match, NHANES II Mortality Study,
1992 staff concluded that the available
evidence was not convincing enough to
determine that the match pertained to
the NHANES II participant. Thus,
NHANES II Mortality Study, 1992 staff
assumed that the participants were still
alive. Matches with a ‘‘possible’’ code
will be stored on internal NCHS files
for later investigation if the participant
does not match to a national data base
after a reasonable amount of time.
Participants with a final ‘‘false’’ match
were also assumed alive.
In all, 2,145 deaths were identified
using the process described earlier. The
numbers of deaths by year of follow-up
and sources of mortality data are
presented in table 1. Between 1976 and
1978, 84 deaths were identified through
DMF, the only source of mortality
information available for this period.
Between 1979 and 1988, 863 deaths
were identified through NDI and DMF,
363 deaths by NDI alone, and 88 deaths
by DMF alone. During the final period
1989–92, 747 deaths were identified
through the NDI, the only source
available. A small percentage of the
deaths that occurred between 1979–88
were identified through DMF
(4.1 percent) and were not found
through NDI. In these cases,
NHANES II Mortality Study, 1992 staff
reviewed the death certificates and
confirmed the deaths.
Causes of Death
For most deaths identified through
the NDI, causes of death were obtained
from the NCHS Multiple Cause of
Death (MCD) file (9,10) by matching on
the death certificate number. These
deaths were coded by nosologists in the
individual State vital statistics offices or
at NCHS according to the International
Classification of Diseases, Ninth
Revision (ICD–9). Death certificateswere ordered for all deaths identified
only through the DMF. The causes of
death for these participants were coded
by nosologists at NCHS using the same
criteria as those used for the MCD file.
Additionally, death certificates were
ordered and causes of death coded for a
small percentage of NDI-identified
deaths from States that did not have
100 percent coverage on the MCD file.
Multiple causes of death are
available for 98 percent (n = 2,104) of
decedents, and, thus, are missing for 41
decedents. Causes of death were missing
if the death certificate could not be
found in State vital statistics offices.
Additionally, causes of death were not
obtained for a few deaths that were later
determined to be missing from the MCD
file.
The date of death was abstracted
from either the file returned by NDI or
the death certificate.
Assessment of the
NHANES II Mortality
Study, 1992
The main advantage of usingpassive follow-up methods is thelow cost of tracing large,
dispersed cohorts. Nevertheless, reliance
solely on these methods to ascertain
mortality introduces some uncertainty
and potential biases (11). Previous
studies have estimated the sensitivity of
matching to the NDI at 87 to 97 percent.
As in the NHANES II Mortality Study,
1992, these studies used name and date
of birth as initial matching criteria with
additional information, such as gender,
race, and marital status, to eliminate
false matches (12–15). Estimates of the
sensitivity of searching the SSA DMF
are unavailable from previous studies
when the Social Security number is not
used in the matching process. In this
study the sensitivity of matching to
DMF with the NHANES II Mortality
Study, 1992 study protocol was
70 percent, using overlapping data for
the period 1979–88 from the DMF and
NDI and using NDI as the ‘‘gold
standard.’’
Page 6 [ Series 1, No. 38Given the limitations of passive
methods, the survival of the NHANES II
Mortality Study, 1992 cohort was
compared to that of the U.S. population
during the same period to assess how
well mortality was ascertained in the
NHANES II Mortality Study, 1992. The
overall performance of the combined
results from the NDI and DMF searches
were evaluated by examining cumulative
survival rates after 5 and 10 years.
Additionally, the number of expected
deaths were compared with observed
deaths for the period covered solely by
DMF because matching to DMF
appeared to be less sensitive than
matching to NDI.
Methods Used
To assess how well mortality was
ascertained in the NHANES II Mortality
Study, 1992, the survival of the cohort
was compared to that of the U.S.
population during the same period.
Cumulative survival probabilities after 5
and 10 years were calculated for 24
race-sex-age groups in the NHANES II
Mortality Study, 1992 cohort using the
Kaplan-Meier product limit method (16).
Sample weights were used to calculate
estimates for the cohort but the complex
sample design of NHANES II was not
taken into account. Cumulative survival
probabilities (nP0) for the U.S.
population after 5 and 10 years were
calculated using mortality rates extracted
from U.S. life tables according to
formula (1):
nP0 = ∏
i = 0
n − 1
[1 − 1qa + i, 1978 + i]
(1)
where
n = number of years of follow-up
1qx , y = probability that persons in a
given race-sex group alive at
age x will die within 1 year
according to the U.S. life table
for year y
a = midpoint of the age interval at
baseline (1978)
The year 1978 was used as the
beginning of follow-up because it was
the approximate midpoint ofNHANES II. Mortality rates for
successive years from life tables were
used to account for the decrease in U.S.
death rates that occurred over the
follow-up period. Participants of race
groups other than white and black were
omitted from this analysis because of
their small numbers in the NHANES II
Mortality Study, 1992 cohort.
To evaluate mortality ascertainment
for the years covered solely by the
DMF, the number of deaths expected to
occur between 1976 and 1978 were
estimated and compared with the
observed number of deaths for this
period. Mortality rates for each race,
sex, and age group from U.S. life tables
were used to calculate the expected
number of survivors at the beginning of
1979 (n1979) as:
n1979 = [O1976 (1 − qa, 19761/2)
(1 − qa + 1, 1977) (1 − qa + 2, 1978)]
+[O1977 (1 − qa, 19771/2)
(1 − qa + 1, 1978)]
+[O1978 (1 − qa, 19781/2)] (2)
where
Oy = number examined during year y
1qx, y = probability that persons in a
given race-sex group alive at
age x will die within 1 year
according to the U.S. life table
for year y
a = midpoint of the age interval at
baseline
The expected number of deaths in each
race-age-sex group was then calculated
as the difference between the total
number examined from 1976–79
(N1976–78) and the expected number of
survivors during this period (n1979).
Results
The cumulative survival
probabilities for the U.S. population and
the NHANES II Mortality Study, 1992
cohort are presented in table 2 by race,
sex, and age group. The survival
probabilities for the cohort were larger
than for the U.S. population in each of
the four race-sex groups. Differences
between probabilities for the cohort and
the U.S. population were most similaramong white males and females. In both
groups the largest differences after five
years were observed in the oldest age
group but after 10 years, groups with
the largest differences expanded to
include 65–69-year-olds and
60–64-year-old females. The largest
discrepancies between the cohort and
U.S. survival patterns were found
among black men and women.
Compared with white men and women,
differences between survival
probabilities after 5 years of follow-up
were consistently larger in all age
groups and much larger among black
males 70–75 years of age. Differences
between survival probabilities by race
were generally larger after 10 years
compared to 5 years of follow-up.
The expected and observed number
of deaths during 1976–78 are presented
in table 3 by sex and age group for all
race groups combined and in table 4 for
24 selected race-sex-age groups.
Overall, 84 deaths were observed, just
over one-half of the expected deaths
during this period. Ratios of observed to
expected deaths were lowest among
participants 50–59 and 70–75 years of
age and highest among those 60–64 and
65–69 years of age. Observed to
expected ratios were approximately the
same for males and females, although
some variation existed by age group
between the sexes, primarily in the
younger age groups. Ratios were
approximately the same for white males
and white females but lower for black
participants. While the observed to
expected ratio for all age groups
combined was lowest among black
females, there were more age groups
among black males in which none of the
expected deaths were found during the
first 3 years of follow-up.
Discussion
Cumulative survival probabilities
for the NHANES II Mortality Study,
1992 cohort were generally higher than
expected probabilities calculated from
U.S. life table data. Based on the
magnitude of differences between them,
mortality ascertainment was better for
the white participants and worse for the
black participants. Ascertainment after 5
years was poorer among the white
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compared with other age groups,
although it did not change substantially
after 10 years for the oldest age group.
On the other hand, ascertainment among
white females 60 years of age and over
was poorer after 10 years compared
with 5 years. Among black participants
poor ascertainment was not limited to
specific age groups. Although
differences between 5- and 10-year
survival varied by age group among the
black participants, the differences
suggest that ascertainment was generally
poorer after 10 years.
Some differences in mortality
ascertainment were expected given the
NHANES II sample design. NHANES II
was a sample of noninstitutionalized
persons, whereas expected probabilities
were based on data for the entire U.S.
population that included institutionalized
persons with lower survival rates. Given
this design the largest differences were
expected among the oldest age group
and should have decreased over time.
This expectation was consistent with the
results. Mortality ascertainment was
poorest among participants in the oldest
age group during the first 3 years of
follow-up. Larger discrepancies in
5-year survival existed in this age group,
and such differences did not increase
over time except among black females.
However, it is unlikely that the sample
design could explain all of the
differences found between the cohort
and U.S. survival patterns, even among
white men and women.
Incomplete national mortality data
for the first 3 years of follow-up could
have contributed to under ascertainment
of mortality in the NHANES II
Mortality Study, 1992. Because the first
wave of the study included years not
covered by NDI, NHANES II Mortality
Study, 1992 staff relied on the DMF for
finding deaths occurring for 1976–79. In
another study comparing the total
number of deaths on the DMF to U.S.
vital statistics data, the DMF contained
89 percent of all deaths occurring in the
United States between 1975–84 (8).
Thus, at best, only 89 percent of
deaths could be detected in the
NHANES II Mortality Study during
the first 3 years of follow-up. The
percent of deaths actually detectedduring the first 3 years of the study
was much less than this, especially
among black participants 70–75 years
of age at baseline.
Limitations in personal identifying
data for NHANES II participants
probably also contributed to under
ascertainment. NHANES II was not
designed as a longitudinal study, and
because of this, important personal
identifiers, such as Social Security
number and father’s surname, were not
collected. Furthermore, personal
identifiers were not recorded with as
much care as they would have been if
NHANES II staff had known that
identifiers would be used to link to
national mortality data bases. For
example, some participants only gave
their first and middle initials instead of
complete names and this was accepted
without further probing. Thus, the
quality of personal identifiers was not as
high as it could have been if a
longitudinal component had been
included in the NHANES II design.
Problems with personal identifiers in the
NHANES II Mortality Study would
have affected passive follow-up
throughout the entire follow-up period,
and possibly contributed to larger
differences in survival probabilities
between 5 and 10 years among the
black participants and older women.
Under ascertainment of deaths
during the years covered solely by the
DMF was greater among the black than
among the white participants. Poorer
mortality ascertainment among the black
participants was consistent with larger
discrepancies in 5-year survival for this
group and with previous studies (17,18)
using the DMF. Furthermore,
discrepancies in 10-year survival were
larger among black than white
participants, suggesting that
ascertainment was problematic for the
former group throughout the entire
follow-up period. Previous studies
evaluating the effectiveness of NDI have
suggested that ascertainment may not be
as good for black decedents as it is for
white decedents (12,19,20). In a study
of the survival of the NHEFS cohort,
differences between observed and
expected survival after 5 and 8 years of
follow-up were larger for black than for
white participants (21). Becausemortality was ascertained through active
tracing methods in NHEFS (22), some
of the differential ascertainment by race
in the NHANES II Mortality Study,
1992 may have been independent of the
passive methods used. Other factors
besides under ascertainment may have
contributed to the larger differences in
survival among black participants. In the
NHANES II Mortality Study, 1992,
survival estimates for black participants
may have been less stable than for white
participants, given the smaller number
of black participants compared with
white participants in the NHANES II
sample. Differences by race in the
quality of denominator data used to
calculate the U.S. estimates may also
have affected the comparisons.
In conclusion, the analysis
presented here suggests that after 10
years of follow-up using passive
methods, mortality may have been under
ascertained for the NHANES II
Mortality Study, 1992 cohort. Because
this analysis used expected data based
on the U.S. population, it probably
overestimated the degree of under
ascertainment, but it is unclear by how
much. Nonetheless, the analysis shows
that compared with white participants,
ascertainment of mortality was poorer
among black participants.
NHANES II Mortality
Study, 1992 Analytic
Cohort
Approximately 23 percent(n = 2,145) of the NHANES IIMortality Study, 1992 cohort
(n = 9,250) was found to be deceased
(table 5). The percentage of male
decedents (28.9 percent) was higher than
the percentage of female decedents
(18.1 percent) among all races
combined, a trend that was also
observed within each age group
(table 5). This same pattern, higher
percentages of male decedents compared
with female decedents, was also
observed among the white and black
participants (table 6).
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(n = 7,105) that were not found to be
deceased as of December 31, 1992,
(table 5) may be assumed to be alive for
analytic purposes. This assumption may
potentially result in the misclassification
of vital status for some cohort members
because of the passive methods used in
this study. That is, some true matches
may have been inadvertently eliminated
and some false matches retained. It is
more likely that true matches were
eliminated rather than false matches
retained because NHANES II Mortality
Study, 1992 staff erred on the side of
being conservative in determining
matches. True matches that were
eliminated would continue to
accumulate person-years of follow-up. If
the rate of eliminating true matches is
unrelated to the exposure of interest,
eliminating true matches should not
attenuate risk ratios but may reduce the
statistical power of studies using the
NHANES II Mortality Study, 1992 data
(11). More important, caution should be
exercised when using the NHANES II
Mortality Study, 1992 data to make
comparisons based on race because of
the apparent differential ascertainment of
mortality by race. Researchers using the
NHANES II Mortality Study, 1992 data
should be aware of these study
limitations and consider them when
drawing conclusions based on these
data.
Finally, subjects 60–74 years of age
were oversampled in NHANES II and,
thus, are overrepresented in the
NHANES II Mortality Study, 1992
cohort. Therefore, NCHS recommends
that analysts use the baseline sample
weights and sample design variables to
account for the complex sample design
in analyses of the NHANES II Mortality
Study, 1992 data.References
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Table 1. Number of deaths according to years of follow-up and sources of mortality status information in the the NHANES II Mortality Study,
1992
Year
Source of morality status
DMF1 NDI2 and DMF NDI Total
Number
of deaths Percent
Number
of deaths Percent
Number
of deaths Percent
Number
of deaths Percent
1976–78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84 3.9 . . . . . . . . . 84 3.9
1979–883 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 4.1 863 40.2 363 16.9 1,314 61.3
1989–92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 747 34.8 747 34.8
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172 8.0 863 40.2 1,110 51.7 2,145 100.0
. . . Category not applicable.
1DMF is the Social Security Administration’s Death Master File.
2NDI is National Death Index.
3DMF was available through March 31, 1988. The remainder of 1988 was covered solely by the NDI.
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
Table 2. Comparison of cumulative survival probabilities after 5 and 10 years for the U.S. population compared with those for the
NHANES II Mortality Study cohort according to race, sex, and age group
Race, sex, and age group
5 years 10 years
United States
NHANES II
Mortality Study
cohort1 United States
NHANES II
Mortality Study
cohort1
White male
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.990 0.996 0.977 0.980
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.977 0.987 0.944 0.954
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.940 0.957 0.858 0.891
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.874 0.880 0.735 0.763
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.824 0.835 0.624 0.669
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.744 0.811 0.485 0.550
White female
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.995 0.994 0.988 0.989
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.987 0.981 0.968 0.968
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.969 0.989 0.923 0.937
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.938 0.952 0.852 0.902
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.908 0.935 0.780 0.847
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.857 0.904 0.668 0.720
Black male
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.974 0.995 0.940 0.977
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.948 1.000 0.883 0.980
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.892 0.943 0.770 0.836
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.827 0.887 0.654 0.834
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.782 0.846 0.556 0.711
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.715 0.872 0.451 0.595
Black female
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.989 1.000 0.973 0.989
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.973 0.952 0.938 0.924
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.942 1.000 0.865 0.964
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.901 0.929 0.784 0.866
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.869 0.942 0.706 0.859
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.812 0.892 0.600 0.723
1Sample weights from the Second National Health and Nutrition Examination Survey were used.
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Table 3. Expected number of survivors and decedents based on U.S. vital statistics data compared with observed number of decedents
from 1976–78 in the NHANES II Mortality Study according to sex and age for all races combined
Sex and age group
Number
examined
Expected
number of
survivors
Expected
number of
decedents
Observed
number of
decedents
Ratio of
observed to
expected
Male1
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 629 626 3 – –
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 497 493 4 3 0.75
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 511 501 10 2 0.20
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 631 607 24 18 0.75
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 495 468 27 19 0.70
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 373 345 28 12 0.43
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,136 3,040 96 54 0.56
Female1
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 697 696 1 2 2.00
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 541 538 3 1 0.33
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 591 585 6 3 0.50
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 660 648 12 6 0.50
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 585 570 15 11 0.73
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 452 433 19 7 0.37
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,526 3,470 56 30 0.54
Total1
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,326 1,322 4 2 0.50
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,038 1,031 7 4 0.57
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,102 1,086 16 5 0.31
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,291 1,255 36 24 0.67
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,080 1,038 42 30 0.71
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 825 778 47 19 0.40
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,662 6,510 152 84 0.55
– Quantity zero.
1Includes races other than white and black.
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Table 4. Expected number of survivors and decedents based on U.S. vital statistics data compared with observed number of decedents
from 1976–78 in the NHANES II Mortality Study according to race, sex, and age for selected race groups
Race, sex, and age group
Number
examined
Expected
number of
survivors
Expected
number of
decedents
Observed
number of
decedents
Ratio of
observed to
expected
White male
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 549 547 2 – –
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 442 439 3 3 1.00
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 455 447 8 2 0.25
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 572 551 21 14 0.67
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 428 406 22 15 0.68
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 329 305 24 12 0.50
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,775 2,695 80 46 0.58
White female
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 602 601 1 2 2.00
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 457 455 2 – –
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 503 499 4 3 0.75
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 588 578 10 5 0.50
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 517 504 13 10 0.77
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 410 394 16 6 0.38
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,077 3,031 46 26 0.57
Black male
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 62 61 1 – –
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 38 1 – –
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 45 2 – –
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 52 49 3 4 1.33
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 48 44 4 3 0.75
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 33 4 – –
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 285 270 15 7 0.47
Black female
30–39 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 82 82 – – . . .
40–49 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 72 71 1 1 1.00
50–59 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 74 72 2 – –
60–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 58 2 1 0.50
65–69 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 53 2 1 0.50
70–75 years . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 35 3 1 0.33
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 381 371 10 4 0.40
– Quantity zero.
. . . Category not applicable.
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Table 5. Number of participants in the NHANES II Mortality Study by mortality status at end of follow-up in 1992 according to sex and age at
baseline for all races combined
Sex and age group Total
Status at follow-up
Assumed alive1 Decedents
Number Percent Number Percent
Male2
30–39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 871 832 95.5 39 4.5
40–49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 691 629 91.0 62 9.0
50–59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 700 565 80.7 135 19.3
60–64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 877 548 62.5 329 37.5
65–69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 697 339 48.6 358 51.4
70–75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 513 178 34.7 335 65.3
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,349 3,091 71.1 1,258 28.9
Female2
30–39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 988 968 98.0 20 2.0
40–49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 766 719 93.9 47 6.1
50–59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 795 701 88.2 94 11.8
60–64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 926 727 78.5 199 21.5
65–69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 799 565 70.7 234 29.3
70–75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 627 334 53.3 293 46.7
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,901 4,014 81.9 887 18.1
Total2
30–39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,859 1,800 96.8 59 3.2
40–49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,457 1,348 92.5 109 7.5
50–59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,495 1,266 84.7 229 15.3
60–64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,803 1,275 70.7 528 29.3
65–69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,496 904 60.4 592 39.6
70–75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,140 512 44.9 628 55.1
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,250 7,105 76.8 2,145 23.2
1Not found to be deceased, therefore, assumed alive.
2Includes races other than white and black.
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Table 6. Number of participants in the NHANES II Mortality Study by mortality status at end of follow-up in 1992 according to race, sex, and
age at baseline for selected race groups
Race, sex, and age group Total
Status at follow-up
Assumed alive1 Decedents
Number Percent Number Percent
White male
30–39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 750 719 95.9 31 4.1
40–49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 610 560 91.8 50 8.2
50–59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 611 500 81.8 111 18.2
60–64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 791 490 62.0 301 38.0
65–69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 605 285 47.1 320 52.9
70–75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 448 152 33.9 296 66.1
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,815 2,706 70.9 1,109 29.1
White female
30–39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 860 843 98.0 17 2.0
40–49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 654 618 94.5 36 5.5
50–59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 677 595 87.9 82 12.1
60–64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 828 653 78.9 175 21.1
65–69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 696 491 70.6 205 29.4
70–75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 559 296 53.0 263 47.0
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,274 3,496 81.8 778 18.2
Black male
30–39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98 91 92.9 7 7.1
40–49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63 52 82.5 11 17.5
50–59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 56 70.9 23 29.1
60–64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78 52 66.7 26 33.3
65–69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73 41 56.2 32 43.8
70–75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58 23 39.7 35 60.3
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 449 315 70.2 134 29.8
Black female
30–39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111 108 97.3 3 2.7
40–49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98 88 89.8 10 10.2
50–59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103 92 89.3 11 10.7
60–64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 66 77.6 19 22.4
65–69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 61 69.3 27 30.7
70–75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 36 56.2 28 43.8
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 549 451 82.1 98 17.8
1Not found to be deceased, therefore, assumed alive.
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Appendix I
NHANES II baseline examination components for participants 30–75 years of age
(1976–80)
Examination components
Test group
Bile acids Glucose tolerance
Urine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Body measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Physician examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Venipuncture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Dietary interview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Allergy test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Electrocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Chest and neck x rays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Back x ray
30–75 years for men . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
50–75 years for women . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Glucose tolerance test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Bile acids test: 35–75 years only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Appendix II
NHANES II baseline blood and urine assessments by specimen types for participants
30–75 years of age (1976–80)
Test group
Bile acids1 Glucose tolerance
Whole blood
Lead: Odd-numbered examinees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Carboxyhemoglobin: Even-numbered examinees . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Protoporphyrin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Red blood cell folate2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Serum
Ferritin2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Bile acids: 35–75 years only . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Cholesterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Triglyceride . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
High density lipoprotein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Pesticides: All examinees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Creatinine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Syphilis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Iron . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Total iron binding capacity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Folate2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Vitamin B122 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Copper . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Zinc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Albumin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Glucose tolerance 75 gram load at 0-, 1-, and 2-hour intervals . . . . . . . . . . . . . . . . . . X
Vitamin C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Urine
N-Multistix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
Gonorrhea:
30–40 years for both sexes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X X
30–40 years for men . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Specific gravity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Pesticides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
1Bilirubin, SGOT, and alkaline phosphatase performed only on those samples with elevated bile acids.
2Performed only on those samples with abnormal complete blood count, hemoglobin, hematocrit, or mean corpuscular volume.
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Appendix III
NHANES II baseline pesticide residue and metabolite determinations for participants
30–75 years of age (1976–80)
Serum Urine
Hexachlorobenzene alpha Monocarboxylic acid
trans Nonachlor Dicarboxylic acid
DDT and Associated Analogs 3,5,6-Trichloro-2-pyridinol
alpha-BHC Isopropoxyphenol
gamma-BHC Carbofuranphenol
beta-BHC 3-Ketocarbofuran
delta-BHC Dicamba
Aldrin 2,4-D
Dieldrin Pentachlorophenol
Endrin para-Nitrophenol
Heptachlor alpha-Naphthol
Heptachlor Epoxide DMTP
Oxychlordane DETP
Mirex DMDTP
DEDTP
DMP
DEP
2,4,5-T
Silvex
2,4,5-Trichlorophenol
NOTE: NHANES II is the Second National Health and Nutrition Examination Survey.
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Vital and Health Statistics
series descriptionsSERIES 1. Programs and Collection Procedures—These reports describe
the data collection programs of the National Center for Health
Statistics. They include descriptions of the methods used to
collect and process the data, definitions, and other material
necessary for understanding the data.
SERIES 2. Data Evaluation and Methods Research—These reports are
studies of new statistical methods and include analytical
techniques, objective evaluations of reliability of collected data,
and contributions to statistical theory. These studies also include
experimental tests of new survey methods and comparisons of
U.S. methodology with those of other countries.
SERIES 3. Analytical and Epidemiological Studies—These reports present
analytical or interpretive studies based on vital and health
statistics. These reports carry the analyses further than the
expository types of reports in the other series.
SERIES 4. Documents and Committee Reports—These are final reports of
major committees concerned with vital and health statistics and
documents such as recommended model vital registration laws
and revised birth and death certificates.
SERIES 5. International Vital and Health Statistics Reports—These
reports are analytical or descriptive reports that compare U.S.
vital and health statistics with those of other countries or present
other international data of relevance to the health statistics
system of the United States.
SERIES 6. Cognition and Survey Measurement—These reports are from
the National Laboratory for Collaborative Research in Cognition
and Survey Measurement. They use methods of cognitive science
to design, evaluate, and test survey instruments.
SERIES 10. Data From the National Health Interview Survey—These
reports contain statistics on illness; unintentional injuries;
disability; use of hospital, medical, and other health services; and
a wide range of special current health topics covering many
aspects of health behaviors, health status, and health care
utilization. They are based on data collected in a continuing
national household interview survey.
SERIES 11. Data From the National Health Examination Survey, the
National Health and Nutrition Examination Surveys, and the
Hispanic Health and Nutrition Examination Survey—Data
from direct examination, testing, and measurement on
representative samples of the civilian noninstitutionalized
population provide the basis for (1) medically defined total
prevalence of specific diseases or conditions in the United States
and the distributions of the population with respect to physical,
physiological, and psychological characteristics, and (2) analyses
of trends and relationships among various measurements and
between survey periods.
SERIES 12. Data From the Institutionalized Population Surveys—
Discontinued in 1975. Reports from these surveys are included in
Series 13.
SERIES 13. Data From the National Health Care Survey—These reports
contain statistics on health resources and the public’s use of
health care resources including ambulatory, hospital, and
long-term care services based on data collected directly from
health care providers and provider records.SERIES 14. Data on Health Resources: Manpower and Facilities—
Discontinued in 1990. Reports on the numbers, geographic
distribution, and characteristics of health resources are now
included in Series 13.
SERIES 15. Data From Special Surveys—These reports contain statistics on
health and health-related topics collected in special surveys that
are not part of the continuing data systems of the National
Center for Health Statistics.
SERIES 16. Compilations of Advance Data From Vital and Health
Statistics—Advance Data Reports provide early release of
information from the National Center for Health Statistics’ health
and demographic surveys. They are compiled in the order in
which they are published. Some of these releases may be
followed by detailed reports in Series 10–13.
SERIES 20. Data on Mortality—These reports contain statistics on mortality
that are not included in regular, annual, or monthly reports.
Special analyses by cause of death, age, other demographic
variables, and geographic and trend analyses are included.
SERIES 21. Data on Natality, Marriage, and Divorce—These reports
contain statistics on natality, marriage, and divorce that are not
included in regular, annual, or monthly reports. Special analyses
by health and demographic variables and geographic and trend
analyses are included.
SERIES 22. Data From the National Mortality and Natality
Surveys—Discontinued in 1975. Reports from these sample
surveys, based on vital records, are now published in Series 20
or 21.
SERIES 23. Data From the National Survey of Family Growth—These
reports contain statistics on factors that affect birth rates,
including contraception, infertility, cohabitation, marriage,
divorce, and remarriage; adoption; use of medical care for family
planning and infertility; and related maternal and infant health
topics. These statistics are based on national surveys of women
of childbearing age.
SERIES 24. Compilations of Data on Natality, Mortality, Marriage,
Divorce, and Induced Terminations of Pregnancy—These
include advance reports of births, deaths, marriages, and divorces
based on final data from the National Vital Statistics System that
were published as supplements to the Monthly Vital Statistics
Report (MVSR). These reports provide highlights and summaries
of detailed data subsequently published in Vital Statistics of the
United States. Other supplements to the MVSR published here
provide selected findings based on final data from the National
Vital Statistics System and may be followed by detailed reports
in Series 20 or 21.
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